CH32018: Synthesis, development and design of pharmaceuticals
[Page last updated: 23 April 2025]
Academic Year: | 2025/26 |
Owning Department/School: | Department of Chemistry |
Credits: | 15 [equivalent to 30 CATS credits] |
Notional Study Hours: | 300 |
Level: | Honours (FHEQ level 6) |
Period: |
|
Assessment Summary: | CWES 17%, CWPG 17%, CWRI 33%, EXCB 33% |
Assessment Detail: |
|
Supplementary Assessment: |
|
Requisites: | Before taking this module you must take CH22011 |
Learning Outcomes: |
Outline the reagents, conditions and reaction mechanisms of relevant transformations for the synthesis and functionalisation of heterocyclic compounds;
Analyse and solve problems relating to the multi-step synthesis of small organic molecules;
Evaluate and propose synthetic routes to small-molecule drug targets;
Evaluate and propose strategies used for the development of major blockbuster drugs and discuss the factors that contribute to their success in the market;
Plan and propose a hit-to-lead drug development strategy based upon analysis and evaluation of biological data. |
Synopsis: | This unit will cover key reactions and approaches towards the synthesis and functionalisation of core motifs within small molecular drugs. Case studies on the discovery and development of major blockbuster drugs will be discussed. You will also participate in a hit-to-lead drug design exercise using your knowledge of different areas of the drug discovery process. |
Content: | This unit will include the following topics: Reactions for the synthesis of heterocycles; Reactions for the functionalisation of heterocycles
Multicomponent reactions; Development of blockbuster drugs (case studies); Virtual drug-design exercise. |
Course availability: |
CH32018 is Compulsory on the following courses:Department of Chemistry
|
Notes:
|